Strides Pharma Science Ltd consolidated Q1FY26 profit at Rs. 99.60 crores

Strides Pharma Science Limited has reported Consolidated financial results for the period ended June 30, 2025.

Financial Results (Q1 FY2026) - QoQ Comparison

The company has reported total income of Rs. 1128.319 crores during the period ended June 30, 2025 as compared to Rs. 1202.372 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs. 99.608 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs. 82.194 crores for the period ended March 31, 2025.

The company has reported EPS of Rs. 10.81 for the period ended June 30, 2025 as compared to Rs. 8.92 for the period ended March 31, 2025.

Financials	Q1 FY2026	Q4 FY2025	% Change
Total Income	₹ 1128.319 crs	₹1202.372 crs	-6.16%
Net Profit	₹99.608 crs	₹82.194 crs	21.19%
EPS	₹10.81	₹8.92	21.19%

Financial Results (Q1 FY2026) - YoY Comparison

The company has reported total income of Rs. 1128.319 crores during the period ended June 30, 2025 as compared to Rs.1067.057 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs.99.608 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs.3351.472 crores for the period ended June 30, 2024.

The company has reported EPS of Rs.10.81 for the period ended June 30, 2025 as compared to Rs.363.96 for the period ended June 30, 2024.

Financials	Q1 FY2026	Q1 FY2025	% Change
Total Income	₹ 1128.319 crs	₹1067.057 crs	5.74%
Net Profit	₹99.608 crs	₹3351.472 crs	-97.03%
EPS	₹10.81	₹363.96	-97.03%

Shares of Strides Pharma Science Limited was last trading in BSE at Rs. 955.10 as compared to the previous close of Rs. 922.50. The total number of shares traded during the day was 134304 in over 6273 trades.

The stock hit an intraday high of Rs. 971.90 and intraday low of 919.00. The net turnover during the day was Rs. 127758778.00.

Source : Equity Bulls

Keywords

StridesPharmaScience Q1FY26 Q1FY2026 FY2026 ResultUpdate